跳至主要内容
临床试验/ACTRN12618000210279
ACTRN12618000210279已完成3 期

asal High Flow therapy versus standard oxygen delivery for Children with Acute Hypoxemic Respiratory Failure - a Randomised Controlled Trial to evaluate hospital length of stay and treatment failure.

Paediatric Critical Care Research Group0 个研究点目标入组 1,512 人开始时间: 2018年2月9日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,512

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
1 Years 至 4 Years(—)
性别
All

入选标准

  • Children aged 1-4 years of age (up to but excluding 5th birthday) with the clinical diagnosis of an Acute Hypoxemic Respiratory Failure disease process such as acute lower respiratory tract infection or asthma, or pnuemonia as examples, and an oxygen requirement in room air (SpO2 <90/92%)
  • Included are infants with reactive airway disease >12 months and an oxygen requirement in room air (SpO2 <90/92%). This includes infants >12 months with the diagnosis of bronchiolitis
  • Informed consent from parents or guardians

排除标准

  • Oxygen requirement and therapy in the emergency department existed for longer than 4 hours prior to inclusion (excludes oxygen given in ambulance or other hospital)
  • Previous use of NHF therapy
  • Upper airway obstruction
  • Craniofacial malformations
  • Critically ill infants requiring immediate higher level of respiratory support i.e. NIV or invasive ventilation, low level of consciousness.
  • Basal skull fracture
  • Cyanotic Heart Disease
  • Home Oxygen therapy
  • Apnoeas (defined as requiring respiratory support such as NIV or mechanical ventilation)
  • Cystic Fibrosis
  • Oncology patients
  • Palliative Care patients
  • Child protection case

研究者

发起方
Paediatric Critical Care Research Group

相似试验

asal High Flow therapy for Children with Acute... | 临床试验